Naloxone blocks 'anxiolytic' effects of neuropeptide Y
by
Britton KT, Southerland S.
Department of Psychiatry,
San Diego VA Medical Center and University of California,
92161, San Diego, CA, USA
Peptides 2001 Apr; 22(4):607-612


ABSTRACT

Intracerebroventricular injection of neuropeptide Y (NPY) produces potent 'anxiolytic' effects in animal models of anxiety. Administration of opioid receptor antagonists suppresses NPY-induced food intake and thermogenesis. The present study examined whether the opiate antagonist naloxone would also suppress the 'anxiolytic' effects of neuropeptide Y. Following training and stabilization of responding in an operant conflict model of anxiety, rats were injected with either NPY or diazepam. Both NPY (veh., 2, 4, 6 ?g, icv) and chlordiazepoxide (veh., 2, 4, 6 mg/kg, i.p.) produced a dose-dependent increase in punished responding in the conflict test. The 'anxiolytic' effects of NPY were not blocked by the administration of flumazenil (3, 6, 12 mg/kg, ip). The administration of naloxone (0.25-2.0 mg/kg, s.c) antagonized the effects of NPY. Central administration of the selective mu opiate antagonist CTAP (1 ?g, icv) partially blocked NPY-induced conflict responding. These results support the hypothesis that NPY may play an important role in experimental anxiety independent of the benzodiazepine receptor and further implicate the opioid system in the behavioral expression of anxiety.

Anxiety
Naloxone
Citalopram
SSRIs/SNRIs
Comparisons
Neurotrophins
Neuropeptide Y

Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family